Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chong-Kin Liam

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Translational Lung Cancer Research|January 5, 2018
Osimertinib as first-line treatment of <i>EGFR</i> mutant advanced non-small-cell lung cancerChong-Kin Liam
Respirology (Carlton, Vic.)|December 6, 2019
Tumour mutation burden of non-small cell lung cancer with pre-existing ILDChong-Kin Liam
Respirology (Carlton, Vic.)|September 14, 2017
Role of routine post-operative laryngeal endoscopic assessment after lung cancer surgeryChong-Kin Liam
Annals of Translational Medicine|March 26, 2019
Central nervous system activity of first-line osimertinib in epidermal growth factor receptor-mutant advanced non-small cell lung cancerChong-Kin Liam
Journal of Thoracic Disease|April 19, 2019
The role of osimertinib in <i>epidermal growth factor receptor</i> (<i>EGFR</i>)-mutant non-small cell lung cancerChong-Kin Liam
Respirology (Carlton, Vic.)|November 5, 2005
Gemcitabine and carboplatin in the treatment of locally advanced and metastatic non-small cell lung cancerChai-Hooi Leow, Chong-Kin Liam
The Malaysian Journal of Pathology|October 4, 2005
Mucinous carcinoma (colloid carcinoma) of the lung diagnosed by fine needle aspiration cytology: a case reportGita Jayaram, Roshidah Yaccob, Chong Kin Liam
Respirology (Carlton, Vic.)|April 27, 2020
Is tissue still the issue in detecting molecular alterations in lung cancer?Chong-Kin Liam, Sugamya Mallawathantri, Kwun M Fong
Respirology (Carlton, Vic.)|October 21, 2006
Pulmonary tuberculosis presenting as community-acquired pneumoniaChong-Kin Liam, Yong-Kek Pang, Shyamala Poosparajah
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 24, 2017
Small Cell Transformation and T790M Mutation as Coresistance Mechanisms for First-line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy FailureChee Shee-Chai, Chong-Kin Liam, Kein-Seong Mun
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Translational Lung Cancer Research|January 5, 2018
Osimertinib as first-line treatment of <i>EGFR</i> mutant advanced non-small-cell lung cancerChong-Kin Liam
Respirology (Carlton, Vic.)|December 6, 2019
Tumour mutation burden of non-small cell lung cancer with pre-existing ILDChong-Kin Liam
Respirology (Carlton, Vic.)|September 14, 2017
Role of routine post-operative laryngeal endoscopic assessment after lung cancer surgeryChong-Kin Liam
Annals of Translational Medicine|March 26, 2019
Central nervous system activity of first-line osimertinib in epidermal growth factor receptor-mutant advanced non-small cell lung cancerChong-Kin Liam
Journal of Thoracic Disease|April 19, 2019
The role of osimertinib in <i>epidermal growth factor receptor</i> (<i>EGFR</i>)-mutant non-small cell lung cancerChong-Kin Liam
Respirology (Carlton, Vic.)|November 5, 2005
Gemcitabine and carboplatin in the treatment of locally advanced and metastatic non-small cell lung cancerChai-Hooi Leow, Chong-Kin Liam
The Malaysian Journal of Pathology|October 4, 2005
Mucinous carcinoma (colloid carcinoma) of the lung diagnosed by fine needle aspiration cytology: a case reportGita Jayaram, Roshidah Yaccob, Chong Kin Liam
Respirology (Carlton, Vic.)|April 27, 2020
Is tissue still the issue in detecting molecular alterations in lung cancer?Chong-Kin Liam, Sugamya Mallawathantri, Kwun M Fong
Respirology (Carlton, Vic.)|October 21, 2006
Pulmonary tuberculosis presenting as community-acquired pneumoniaChong-Kin Liam, Yong-Kek Pang, Shyamala Poosparajah
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 24, 2017
Small Cell Transformation and T790M Mutation as Coresistance Mechanisms for First-line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy FailureChee Shee-Chai, Chong-Kin Liam, Kein-Seong Mun
Pageof 9